,title,source,link,date
21,CPHI & PMEC India Expo returns with renewed vision for pharmaceutical landscape,ETHealthWorld,news.google.com/articles/CBMinwFodHRwczovL2hlYWx0aC5lY29ub21pY3RpbWVzLmluZGlhdGltZXMuY29tL25ld3MvcGhhcm1hL3BoYXJtYS1pbmR1c3RyeS9jcGhpLXBtZWMtaW5kaWEtZXhwby1yZXR1cm5zLXdpdGgtcmVuZXdlZC12aXNpb24tZm9yLXBoYXJtYWNldXRpY2FsLWxhbmRzY2FwZS8xMDUzODU5NDjSAaMBaHR0cHM6Ly9oZWFsdGguZWNvbm9taWN0aW1lcy5pbmRpYXRpbWVzLmNvbS9hbXAvbmV3cy9waGFybWEvcGhhcm1hLWluZHVzdHJ5L2NwaGktcG1lYy1pbmRpYS1leHBvLXJldHVybnMtd2l0aC1yZW5ld2VkLXZpc2lvbi1mb3ItcGhhcm1hY2V1dGljYWwtbGFuZHNjYXBlLzEwNTM4NTk0OA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-21
55,"Cytokines Market worth $149.25 billion by 2030, growing at a CAGR of 8.75% - Exclusive Report by 360iResearch",openPR,news.google.com/articles/CBMiY2h0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjk1NjQ4L2N5dG9raW5lcy1tYXJrZXQtd29ydGgtMTQ5LTI1LWJpbGxpb24tYnktMjAzMC1ncm93aW5nLWF0LWEtY2FnctIBYmh0dHBzOi8vd3d3Lm9wZW5wci5jb20vYW1wLzMyOTU2NDgvY3l0b2tpbmVzLW1hcmtldC13b3J0aC0xNDktMjUtYmlsbGlvbi1ieS0yMDMwLWdyb3dpbmctYXQtYS1jYWdy?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-21
6,M&A and investing activity in the Indian healthcare sector has been strong over the last 4-5 years and is li..,ETHealthWorld,news.google.com/articles/CBMi2AFodHRwczovL2hlYWx0aC5lY29ub21pY3RpbWVzLmluZGlhdGltZXMuY29tL25ld3MvaW5kdXN0cnkvbWEtYW5kLWludmVzdGluZy1hY3Rpdml0eS1pbi10aGUtaW5kaWFuLWhlYWx0aGNhcmUtc2VjdG9yLWhhcy1iZWVuLXN0cm9uZy1vdmVyLXRoZS1sYXN0LTQtNS15ZWFycy1hbmQtaXMtbGlrZWx5LXRvLWNvbnRpbnVlLWF0LXJvYnVzdC1sZXZlbHMtaW4tMjAyNC8xMDUzMzI1NTbSAdwBaHR0cHM6Ly9oZWFsdGguZWNvbm9taWN0aW1lcy5pbmRpYXRpbWVzLmNvbS9hbXAvbmV3cy9pbmR1c3RyeS9tYS1hbmQtaW52ZXN0aW5nLWFjdGl2aXR5LWluLXRoZS1pbmRpYW4taGVhbHRoY2FyZS1zZWN0b3ItaGFzLWJlZW4tc3Ryb25nLW92ZXItdGhlLWxhc3QtNC01LXllYXJzLWFuZC1pcy1saWtlbHktdG8tY29udGludWUtYXQtcm9idXN0LWxldmVscy1pbi0yMDI0LzEwNTMzMjU1Ng?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-19
3,Diwali Muhurat Trading 2023: Glenmark Pharma share price opens almost 10% lower after Q2 result | Mint,Mint,news.google.com/articles/CBMiowFodHRwczovL3d3dy5saXZlbWludC5jb20vbWFya2V0L3N0b2NrLW1hcmtldC1uZXdzL2Rpd2FsaS1tdWh1cmF0LXRyYWRpbmctMjAyMy1nbGVubWFyay1waGFybWEtc2hhcmUtcHJpY2Utb3BlbnMtYWxtb3N0LTEwLWxvd2VyLWFmdGVyLXEyLXJlc3VsdC0xMTY5OTc5NDU4MTI0NC5odG1s0gGnAWh0dHBzOi8vd3d3LmxpdmVtaW50LmNvbS9tYXJrZXQvc3RvY2stbWFya2V0LW5ld3MvZGl3YWxpLW11aHVyYXQtdHJhZGluZy0yMDIzLWdsZW5tYXJrLXBoYXJtYS1zaGFyZS1wcmljZS1vcGVucy1hbG1vc3QtMTAtbG93ZXItYWZ0ZXItcTItcmVzdWx0L2FtcC0xMTY5OTc5NDU4MTI0NC5odG1s?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-12
1,Glenmark Pharma reports consolidated revenue growth of 6.3 per cent and adjusted EBITDA growth of 8.3 per cent YoY for Q2 FY 2023-24,Business Standard,news.google.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?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-11
0,Glenmark Pharma reports consolidated revenue growth of 6.3% and ...,PR Newswire,news.google.com/articles/CBMirgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9pbi9uZXdzLXJlbGVhc2VzL2dsZW5tYXJrLXBoYXJtYS1yZXBvcnRzLWNvbnNvbGlkYXRlZC1yZXZlbnVlLWdyb3d0aC1vZi02LTMtYW5kLWFkanVzdGVkLWViaXRkYS1ncm93dGgtb2YtOC0zLXlveS1mb3ItcTItZnktMjAyMy0yNC0tMzAxOTg0ODI0Lmh0bWzSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
2,Glenmark Pharma posts Q2 loss on exceptional legal costs,The Financial Express,news.google.com/articles/CBMidGh0dHBzOi8vd3d3LmZpbmFuY2lhbGV4cHJlc3MuY29tL2J1c2luZXNzL2luZHVzdHJ5LWdsZW5tYXJrLXBoYXJtYS1wb3N0cy1xMi1sb3NzLW9uLWV4Y2VwdGlvbmFsLWxlZ2FsLWNvc3RzLTMzMDQ1MDgv0gF5aHR0cHM6Ly93d3cuZmluYW5jaWFsZXhwcmVzcy5jb20vYnVzaW5lc3MvaW5kdXN0cnktZ2xlbm1hcmstcGhhcm1hLXBvc3RzLXEyLWxvc3Mtb24tZXhjZXB0aW9uYWwtbGVnYWwtY29zdHMtMzMwNDUwOC9saXRlLw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
19,Paracetamol maker Granules India's Q2 revenue rises on higher N ...,Reuters,news.google.com/articles/CBMikQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9wYXJhY2V0YW1vbC1tYWtlci1ncmFudWxlcy1pbmRpYXMtcTItcmV2ZW51ZS1yaXNlcy1oaWdoZXItbmFtZXJpY2EtZGVtYW5kLTIwMjMtMTEtMDkv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
